Adaptive Biotechnologies Corporation (United States) is listed on the Nasdaq and has a market capitalization of $4.47 billion, with shareholders equity totaling $150.66 million.
The company employs approximately 453 people and operates in the Health sector, within the Life Science Tools and Services industry.
Over the past 12 months, Adaptive Biotechnologies Corporation reported $308.08 million in revenue, generating net income of $-63.85 million.
Key financial metrics include a P/E ratio of -69.93, a price-to-book (P/B) ratio of 29.64, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ADPT.